Published on
The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).
Published on
The College of Healthcare Information Management Executives (CHIME) has released their Digital Health Most Wired Survey results for the 2023 data collection period, and Children's Hospital of Philadelphia (CHOP) is excited to announce we have maintained our highest ranking to date: Acute Level 8 achievement for the Digital Health Most Wired range.
Published on
Identifying “backbones” that link complexes can help maximize CAR therapy across different variants and tumor types.
Published on
![Children’s Hospital of Philadelphia’s Center for Violence Prevention Marks A Major Milestone [10 Years of Unified Programming and Research]](https://www.chop.edu/sites/default/files/CVP-10th-ipv-gun-16x9.jpg "Children’s Hospital of Philadelphia’s Center for Violence Prevention Marks A Major Milestone [10 Years of Unified Programming and Research]")
Today, Children’s Hospital of Philadelphia’s Center for Violence Prevention (CVP) marks a major milestone -- 10 years of unified programming and research focused on reducing exposure to and impact of violence on youth and their families.
Published on
All three genes had variants affecting splicing and resulted in symptoms like developmental delays, intellectual disability, hypotonia, seizures and autism.
Published on
This major step allows for the creation of clinical trials to test key endpoints that will determine the efficacy of new therapies.
Published on
An experimental compound might be further developed as an effective treatment approach for affected patients.
Published on
Alexis Thompson, MD, MPH, received the award at the society’s annual meeting.
Published on
Shortly after giving birth at Thomas Jefferson University Hospital, Meredith Alley found herself visiting her son, Graham, in the neonatal intensive care unit (NICU). He had arrived earlier than expected and faced respiratory distress that required special care.
Published on
Children’s Hospital of Philadelphia (CHOP) has received a $6.4 million gift from the family of Connor Boyle, a Central Bucks East High School graduate who died at age 18 from osteosarcoma. This three-year gift, named The Connor Initiative: Precision Therapeutics for Osteosarcoma & Rare Cancers, will support cutting-edge research in osteosarcoma and other rare cancers.